FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211023150> ?p ?o ?g. }

• W4211023150 endingPage "2680" @default.
• W4211023150 startingPage "2667" @default.
• W4211023150 abstract "Mantle cell lymphoma (MCL) is biologically and clinically heterogeneous and would benefit from prognostic biomarkers to guide management. Circulating tumor DNA (ctDNA) is a novel prognostic biomarker in diffuse large B-cell lymphoma that may have applicability in MCL. We analyzed ctDNA dynamics in previously untreated patients with MCL who received induction therapy with bortezomib and DA-EPOCH-R for 6 cycles followed by random assignment to observation or bortezomib maintenance in responding patients in a prospective phase 2 study. Most patients also underwent initial treatment window of bortezomib alone prior to induction. Serum was collected pretreatment, after the window, after cycles 1 and 2, at the end of induction, and at each follow-up visit along with restaging computed tomography scans. Next-generation sequencing was used to identify and quantify ctDNA encoding the immunoglobulin receptor sequences in serum as markers of minimal residual disease. Fifty-three patients were enrolled, with a median follow-up of 12.7 years. Patients without detectable ctDNA after 2 cycles of induction had longer progression-free survival (PFS) and overall survival (OS) compared with those with detectable ctDNA (median PFS, 2.7 vs 1.8 years; overall P = .005; median OS, 13.8 vs 7.4 years; overall P = .03). Notably, in vivo assessment of ctDNA dynamics during the bortezomib window was not prognostic, and there was no difference in PFS or OS with bortezomib maintenance. ctDNA monitoring after induction showed that molecular relapse preceded clinical relapse in some cases. In conclusion, interim ctDNA negativity strongly correlates with improved survival and supports the investigation of response-adapted strategies. This trial was registered at www.clinicaltrials.gov as #NCT00114738." @default.
• W4211023150 created "2022-02-13" @default.
• W4211023150 creator A5000043912 @default.
• W4211023150 creator A5002368482 @default.
• W4211023150 creator A5003400270 @default.
• W4211023150 creator A5015561659 @default.
• W4211023150 creator A5016988477 @default.
• W4211023150 creator A5030524385 @default.
• W4211023150 creator A5043319996 @default.
• W4211023150 creator A5044239219 @default.
• W4211023150 creator A5044366730 @default.
• W4211023150 creator A5049385918 @default.
• W4211023150 creator A5060885349 @default.
• W4211023150 creator A5067251812 @default.
• W4211023150 creator A5069493174 @default.
• W4211023150 creator A5081833588 @default.
• W4211023150 creator A5085324577 @default.
• W4211023150 creator A5089779163 @default.
• W4211023150 date "2022-04-22" @default.
• W4211023150 modified "2023-09-30" @default.
• W4211023150 title "Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma" @default.
• W4211023150 cites W1912693401 @default.
• W4211023150 cites W1974788142 @default.
• W4211023150 cites W1985012922 @default.
• W4211023150 cites W1988737825 @default.
• W4211023150 cites W2001178238 @default.
• W4211023150 cites W2036242721 @default.
• W4211023150 cites W2056952913 @default.
• W4211023150 cites W2065464657 @default.
• W4211023150 cites W2088783247 @default.
• W4211023150 cites W2108242165 @default.
• W4211023150 cites W2112509952 @default.
• W4211023150 cites W2119147717 @default.
• W4211023150 cites W2124235514 @default.
• W4211023150 cites W2125684345 @default.
• W4211023150 cites W2131956233 @default.
• W4211023150 cites W2133869962 @default.
• W4211023150 cites W2137478135 @default.
• W4211023150 cites W2137816642 @default.
• W4211023150 cites W2139047632 @default.
• W4211023150 cites W2158945674 @default.
• W4211023150 cites W2164427041 @default.
• W4211023150 cites W2228849275 @default.
• W4211023150 cites W2345102372 @default.
• W4211023150 cites W2430862255 @default.
• W4211023150 cites W2470400696 @default.
• W4211023150 cites W2551589138 @default.
• W4211023150 cites W2565192467 @default.
• W4211023150 cites W2586369123 @default.
• W4211023150 cites W2587227044 @default.
• W4211023150 cites W2597269601 @default.
• W4211023150 cites W2598700764 @default.
• W4211023150 cites W2744499701 @default.
• W4211023150 cites W2760635695 @default.
• W4211023150 cites W2793121285 @default.
• W4211023150 cites W2804219602 @default.
• W4211023150 cites W2888203943 @default.
• W4211023150 cites W2889531115 @default.
• W4211023150 cites W2896619830 @default.
• W4211023150 cites W2901730480 @default.
• W4211023150 cites W2913355953 @default.
• W4211023150 cites W2932969462 @default.
• W4211023150 cites W2956087440 @default.
• W4211023150 cites W2997154620 @default.
• W4211023150 cites W3009886853 @default.
• W4211023150 cites W3011341107 @default.
• W4211023150 cites W3033787835 @default.
• W4211023150 cites W3037023631 @default.
• W4211023150 cites W3038483739 @default.
• W4211023150 cites W3096166445 @default.
• W4211023150 cites W3140133016 @default.
• W4211023150 cites W3177138969 @default.
• W4211023150 cites W3184558555 @default.
• W4211023150 doi "https://doi.org/10.1182/bloodadvances.2021006397" @default.
• W4211023150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35143622" @default.
• W4211023150 hasPublicationYear "2022" @default.
• W4211023150 type Work @default.
• W4211023150 citedByCount "12" @default.
• W4211023150 countsByYear W42110231502022 @default.
• W4211023150 countsByYear W42110231502023 @default.
• W4211023150 crossrefType "journal-article" @default.
• W4211023150 hasAuthorship W4211023150A5000043912 @default.
• W4211023150 hasAuthorship W4211023150A5002368482 @default.
• W4211023150 hasAuthorship W4211023150A5003400270 @default.
• W4211023150 hasAuthorship W4211023150A5015561659 @default.
• W4211023150 hasAuthorship W4211023150A5016988477 @default.
• W4211023150 hasAuthorship W4211023150A5030524385 @default.
• W4211023150 hasAuthorship W4211023150A5043319996 @default.
• W4211023150 hasAuthorship W4211023150A5044239219 @default.
• W4211023150 hasAuthorship W4211023150A5044366730 @default.
• W4211023150 hasAuthorship W4211023150A5049385918 @default.
• W4211023150 hasAuthorship W4211023150A5060885349 @default.
• W4211023150 hasAuthorship W4211023150A5067251812 @default.
• W4211023150 hasAuthorship W4211023150A5069493174 @default.
• W4211023150 hasAuthorship W4211023150A5081833588 @default.
• W4211023150 hasAuthorship W4211023150A5085324577 @default.
• W4211023150 hasAuthorship W4211023150A5089779163 @default.
• W4211023150 hasBestOaLocation W42110231501 @default.

• next